NxGen Brands, Inc. Proudly Announces the Successful Closing of “Mad House Innovations” Acquisition
Denver, CO – January 9, 2024 – NxGen Brands, Inc. (OTCPK: NXGB) (“NxGen” or the “Company”), (www.nxgenbrands.com) successfully closes its “Mad House Innovations” acquisition. Mad House enjoyed explosive growth in 2023 and we invite the investment community to visit their corporate website to familiarize themselves with their exciting brand: “Mad House Innovations” (www.madhousesupps.com) Mad […]
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 95 million by the year 2060, and it is expected to rise to approximately 23 […]
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
SAN DIEGO, CA and CALGARY, AB – January 9, 2024 – Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced the appointment of Patricia S. Andrews to its Board of Directors (the “Board”). “I am pleased to welcome Pat Andrews to our Board of Directors,” said Dr. […]
